drug

depemokimab

1 story · latest Jul 17, 2026

Status: FDA approved Dec 2025 · BLA761458
Brand: Exdensur
Code: GSK3511294
Trials: 7 registered trials in coverage

Relationships

Developed by GlaxoSmithKline

Timeline

GSK CMV vaccine trial posts results; six new studies span cardiovascular, MASH, CRSwNP

Jul 17Weekly roundup, 6 itemsdepemokimab efimosfermin alfa

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.